This present article identified five myCAFs marker genes that showed highly similar expression patterns and impact on BLCA patients’ prognosis, including ACTA2, TAGLN, MYL9, TPM1, and TPM2. This evidence concerns the gene TPM2 and bladder transitional cell carcinoma.